Overview

Study Evaluating PPM-204 In Subjects With Type 2 Diabetes

Status:
Terminated
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn whether PPM-204 has an effect on lowering blood glucose (blood sugar) levels and is safe in treating people with type 2 diabetes.
Phase:
Phase 2
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer